BIOMATDB

Advanced Database for Biomaterials with Data Analysis and Visualisation Tools extended by a Marketplace with Digital Advisors

Programme: HORIZON-CL4-2021-RESILIENCE-01-25 | CSA under grant agreement No 101058779
Duration: 01/07/2022 – 31/10/2024

Description

Biomaterials in healthcare span almost all medical fields, ranging from recognised materials to high-innovative smart and multifunctional biomaterials. One of the main challenges is to provide accessible and well-structured data of biomaterials for all relevant practitioners and user groups.

BIOMATDB+ aims to create an advanced database for biomaterials providing detailed information on its properties.
The platform will also provide a web-optimised information marketplace and digital advisors to support companies, especially SMEs, in offering their products and properly presenting themselves at global scale.

In addition, BIOMATDB+ will create a label of biocompatibility to define the suitability of a biomaterial for different uses, improving standarization and market access.

Scope and objectives

BIOMATDB+ main objectives are:

ASSESS existing knowledge on biomaterials to identify best practices for material databases
SURVEY relevant stakeholders to gather the requirements of the platform
DEVELOP an advanced database of biomaterials providing detailed information of all relevant properties and intuitive data analysis and visualisation for a variety of end users
CREATE a label of biocompatibility to define the suitability of biomaterials for use in medical devices or advanced therapies to assist companies and SMEs to access markets
LAUNCH a market place with digital advisors to support the decision process.
DEMONSTRATE the database and marketplace usability and feasibility of the business model.
INCREASE awareness and impact through communication and dissemination activities on the purpose of the project and the developed solutions.

ECHAlliance role

The ECHAlliance will be mainly involved in the development of the tools, by facilitating the collaboration with the relevant stakeholders throughout its ecosystems, to ensure suitability to users needs and workflows.

A relevant role of the ECHAlliance is also on the dissemination of the project throughout its member organisations, namely hospitals, health professionals and SMEs, as well as to citizens in general.

Consortium

The BIOMATDB consortium brings together 12 partners from 8 countries, from different disciplines to ensure the project’s multi-disciplinary approach.
A full list of partners can be found here.

Website

Biomatdb